Customer Guest RE-KYC
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
The company reported standalone net loss during the quarter stood at Rs 1.94 crore as compared to net loss of Rs 3.60 crore in the previous year quar...more...
Financial year Results for the year ended 31.03.2025more...
Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that at the Boa...more...
ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia t...more...
The company is not falling under Large Corporate Category as on 31st March 2025.more...
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company ANG Life...more...
Compliance certificate under Reg 74(5) of SEBI (DP) Regulations for quarter ended 31.03.2025.more...
As of March 2025 70.60% is owned by Indian Promoters and 29.40% by Public. Top two Promoters holding highest number of shares of ANG Lifesci...more...
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that Mr. Karun Singh Group...more...
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 the Board of Directors at the meeting held on today March 12 2025 have considered ...more...
The company reported standalone net loss during the quarter stood at Rs 4.57 crore as compared to net loss of Rs 4.59 crore in the previous year quar...more...
Integrated Filling (Financials)more...
Unaudited Financial Results for Quarter and nine months ended 31.12.2024.more...
Pursuant to Regulation 30 & 33 read with clause 4 (h) of Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requir...more...
ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to conside...more...
As of December 2024 70.60% is owned by Indian Promoters and 29.40% by Public. Top two Promoters holding highest number of shares of ANG Life...more...
Disclosure under Reg 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31.12.2024.more...
Resignation of Company Secretary w.e.f. 16.12.2024more...
Enter Stock
BOARD MEETINGS Company Name : Kuberan Global Edu Date : 24-06-2025